Login to Your Account

Financings Roundup

Surface Logix Gets $20M Series E, Starts Phase IIb in Dyslipidemia

By Trista Morrison

Monday, March 9, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription